2023 Guidance and Q3 Earnings slide image

2023 Guidance and Q3 Earnings

Agenda Strong and sustained performance heading into 2024 Emma Walmsley Innovation Dr Tony Wood Performance Luke Miels, Deborah Waterhouse and Julie Brown Summary Emma Walmsley GSK Q&A Emma Walmsley, Tony Wood, Luke Miels, Deborah Waterhouse, Julie Brown, David Redfern 3
View entire presentation